Molecular Master Switch for Pancreatic Cancer Identified, Potential Predictor of Treatment Outcome


February 19, 2013

A Perelman School of Medicine team led by Anil Rustgi has identified a pancreatic cancer molecular master switch that could be used to predict treatment outcomes.

Read more

Find a Clinical Trial